TH1/TH2 cytokine levels as an indicator for disease progression in human immunodeficiency virus type 1 infection and response to antiretroviral therapy.
Chukwunomso Osakwe(University of Bucharest), Veronica Lazăr(University of Bucharest), Coralia Bleoţu, Magda Dinu, Adrian Streinu‐Cercel(Université Claude Bernard Lyon 1), Dan Oţelea, Camelia Grancea, Simona Paraschiv, Mariana Carmen Chifiriuc(University of Bucharest), Sorin Petrea, Cristian Băicuş
PubMed
December 14, 2010
Cited by 30
Related Papers
Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer
|Frontiers in Immunology|2018|535
Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program
|Clinical Infectious Diseases|2012|208
Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)
|Hepatology|2014|165
JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection
|Gastroenterology|2020|116
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries
|Clinical Gastroenterology and Hepatology|2019|111